Author
Listed:
- Doureradjou Peroumal
(University of Pittsburgh
University of Pittsburgh)
- Chetan V. Jawale
(University of Pittsburgh
University of Pittsburgh)
- Wonseok Choi
(University of Pittsburgh
University of Pittsburgh
Stony Brook University)
- Hossein Rahimi
(University of Pittsburgh
University of Pittsburgh
Stony Brook University)
- Danielle Antos
(University of Pittsburgh
University of Pittsburgh)
- De-dong Li
(University of Pittsburgh
University of Pittsburgh)
- Shuxia Wang
(University of Pittsburgh)
- Godhev K. Manakkat Vijay
(University of Pittsburgh
University of Pittsburgh)
- Isha Mehta
(University of Pittsburgh
University of Pittsburgh)
- Raymond West
(University of Pittsburgh)
- Muthusamy Thangaraju
(Augusta University)
- Thomas D. Nolin
(University of Pittsburgh)
- Jishnu Das
(University of Pittsburgh
University of Pittsburgh)
- John F. Alcorn
(University of Pittsburgh
University of Pittsburgh)
- Partha S. Biswas
(University of Pittsburgh
University of Pittsburgh
Stony Brook University)
Abstract
Antibody-mediated protection against pathogens is crucial to a healthy life. However, the recent SARS-CoV-2 pandemic has shown that pre-existing comorbid conditions including kidney disease account for compromised humoral immunity to infections. Individuals with kidney disease are not only susceptible to infections but also exhibit poor vaccine-induced antibody response. Using multiple mouse models of kidney disease, we demonstrate that renal dysfunction inhibits germinal center (GC) response against T-dependent antigens. GC B cells exhibit increased apoptosis in kidney disease. Uremic toxin hippuric acid drives loss of mitochondrial membrane potential, leading to increased apoptosis of GC B cells in a G-protein–coupled receptor 109A dependent manner. Finally, GC B cells and antibody titer are diminished in mice with kidney disease following influenza virus infection, a major cause of mortality in individuals with renal disorders. These results provide a mechanistic understanding of how renal dysfunction suppresses humoral immunity in patients with kidney disease.
Suggested Citation
Doureradjou Peroumal & Chetan V. Jawale & Wonseok Choi & Hossein Rahimi & Danielle Antos & De-dong Li & Shuxia Wang & Godhev K. Manakkat Vijay & Isha Mehta & Raymond West & Muthusamy Thangaraju & Thom, 2024.
"The survival of B cells is compromised in kidney disease,"
Nature Communications, Nature, vol. 15(1), pages 1-19, December.
Handle:
RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-55187-w
DOI: 10.1038/s41467-024-55187-w
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-55187-w. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.